Amneal Aims To Be Among Top Five Biosimilars Players In US
As Company Focuses On Launch Of Three Biosimilars This Year
Amneal’s president and co-CEO, Chirag Patel, has shared the company’s long-term plan of becoming one of the top biosimilars players in the US. The company is set to launch three biosimilars this year, while building its manufacturing capabilities and looking for opportunities and partnerships.
